Doxorubicin Hydrochloride Liposomal 20MG/10ML

About Doxorubicin Hydrochloride Liposomal 20MG/10ML

USP of Product This is a formulation of the drug doxorubicin hydrochloride that uses nanocarriers. The drug is put inside a phospholipid bilayer vesicle that has polyethylene glycol (PEG) attached to its surface. This coating helps the drug stay in the body longerabout 55 hours in peoplebecause it reduces how easily the body can remove it. Because of this, the liposomes can get through the blood vessels of tumors more easily, delivering a lot of doxorubicin to the tumor while not harming normal tissues.

Enhanced Therapeutic Delivery

This liposomal form of Doxorubicin Hydrochloride facilitates targeted drug delivery directly to cancer cells, aiming to reduce systemic toxicity. The advanced formulation is suited for patients requiring long-term therapy, offering improved tolerance and extended shelf life. Sourced from trusted Indian facilities, this medication upholds stringent quality standards for healthcare providers globally.


Versatile Applications

Doxorubicin Hydrochloride Liposomal is commonly prescribed to manage ovarian cancer, multiple myeloma, and AIDS-related Kaposi's sarcoma. The encapsulated design allows for effective drug retention in the body, maximizing the potential therapeutic outcome for patients facing these serious malignancies. Healthcare professionals determine usage based on specific patient needs and diagnosis.